Abstract: The described technology is generally directed towards automated development of machine learning pipelines. An automated framework can extract topics from a data science workspace such as a machine learning notebook, transform and annotate cells of the machine learning notebook to various machine learning pipeline stages, and orchestrate the machine learning pipeline stages in a workflow that can be deployed into production data infrastructures.

Abstract: An improved authentication, identification, and/or verification system is provided in various embodiments. The system is provided for use in relation to provisioning access or establishing identity in relation to one or more human users, and may be used in a single site/scenario/system, or across multiple sites/scenarios/systems. A combination of biometric modalities and authentication mechanisms having diverse characteristics are utilized to establish identity, the diverse characteristics being utilized to modify aspects of identity management and access provisioning.

Abstract: Nuclear fuel rods are disclosed. The nuclear fuel rods include a substrate and a chromium alloy coating layer applied to the substrate. The chromium alloy coating layer comprises chromium (Cr); a element or compound selected from the group consisting of yttrium (Y), lanthanum (La), thorium (Th), zirconium (Zr), titanium (Ti), hafnium (I-lf), molybdenum (Mo), tungsten (W), vanadium (V), rhenium (Re), ruthenium (Ru), cobalt (Co), aluminum (Al), carbides, borides, intermetallics, and combinations thereof; and interstitial elements up to 1500 ppm, wherein carbon (C), oxygen (O), and nitrogen (N) are each 500 ppm or less.

Abstract: The invention relates to a method of treating parasitic etiologies of ophthalmic diseases in the eyelash, eyelid, or cutaneous tissue surrounding the eyelash or eyelid by topically applying to the eyelash, eyelid, or cutaneous tissue surrounding the eyelash or eyelid a formulation of antiparasitic agents such as macrocyclic lactone parasiticides, comprising of suspended particles of ivermectin and polymer solid dispersion in a suitable pharmaceutically carrier. The formulation may include particles of ivermectin and a polymer having a D90 particle size below about 10 microns preferably between about 800 nm and about 4 microns. The polymer may be an extended release polymer. The formulation may further include mineral oil and an anhydrous gel. The formulation may have a viscosity between 30,000 cP and about 100,000 cP preferably between about 40,000 cP and about 90,000 cP.

Abstract: Methods, systems, and apparatus are described herein for tracking objects and managing data. One or more objects may be determined in a first image. An avatar may be generated which is associated with the one or more objects in the first image. A second image may be received. The second image may comprise a change in at least one object of the one or more objects. Based on the change, in the at least one object, the avatar may be updated and the information kept for a predetermined period of time.